Trials / Completed
CompletedNCT04104451
PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study Objective: The objective of this Phase 1 open-label study is to establish the safety and tolerability of Corlicyte mesenchymal stem cells (MSCs) in the treatment of patients with chronic diabetic foot ulcers (DFUs).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corlicyte | expanded umbilical cord lining mesenchymal stem cells |
Timeline
- Start date
- 2019-11-12
- Primary completion
- 2023-08-01
- Completion
- 2023-08-01
- First posted
- 2019-09-26
- Last updated
- 2024-01-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04104451. Inclusion in this directory is not an endorsement.